| Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors L Zapata, G Caravagna, MJ Williams, E Lakatos, K AbdulJabbar, ... Nature Genetics 55 (3), 451-460, 2023 | 17 | 2023 |
| A Bayesian method to cluster single-cell RNA sequencing data using copy number alterations S Milite, R Bergamin, L Patruno, N Calonaci, G Caravagna Bioinformatics 38 (9), 2512-2518, 2022 | 10 | 2022 |
| Transcriptional characterization of stage I epithelial ovarian cancer: a multicentric study E Calura, M Ciciani, A Sambugaro, L Paracchini, G Benvenuto, S Milite, ... Cells 8 (12), 1554, 2019 | 10 | 2019 |
| Computational validation of clonal and subclonal copy number alterations from bulk tumor sequencing using CNAqc A Antonello, R Bergamin, N Calonaci, J Househam, S Milite, MJ Williams, ... Genome Biology 25 (1), 1-40, 2024 | 9* | 2024 |
| Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma S Scalera, B Ricciuti, M Mazzotta, N Calonaci, JV Alessi, L Cipriani, G Bon, ... Annals of Oncology 34 (3), 275-288, 2023 | 6 | 2023 |
| Mutation Rate Evolution Drives Immune Escape in Mismatch Repair-Deficient Cancer H Kayhanian, P Barmpoutis, E Lakatos, W Cross, G Caravagna, L Zapata, ... bioRxiv, 2022.03. 06.482973, 2022 | 2 | 2022 |
| Clinical application of tumour-in-normal contamination assessment from whole genome sequencing J Mitchell, S Milite, J Bartram, S Walker, N Volkova, O Yavorska, ... Nature Communications 15 (1), 323, 2024 | 1 | 2024 |
| A Bayesian method to infer copy number clones from single-cell RNA and ATAC sequencing L Patruno, S Milite, R Bergamin, N Calonaci, A D’Onofrio, F Anselmi, ... PLOS Computational Biology 19 (11), e1011557, 2023 | 1 | 2023 |
| Epigenetic heritability of cell plasticity drives cancer drug resistance through one-to-many genotype to phenotype mapping J Fernandez-Mateos, S Milite, E Oliveira, G Vlachogiannis, B Chen, ... bioRxiv, 2023.11. 15.567140, 2023 | 1 | 2023 |
| Interpretable Multi-Omics Data Integration with Deep Archetypal Analysis S Milite, G Caravagna, A Sottoriva bioRxiv, 2024.04. 05.588238, 2024 | | 2024 |
| Time of Origin and Environmental Drivers of Leukemia Immune Escape after Transplantation C Toffalori, R Bergamin, A Antonello, AF Tortorelli, G Orofino, M Cristante, ... Blood 142, 362, 2023 | | 2023 |
| NeuroVelo: interpretable learning of cellular dynamics from single-cell transcriptomic data I Kouadri Boudjelthia, S Milite, N El Kazwini, J Fernandez-Mateos, ... bioRxiv, 2023.11. 17.567500, 2023 | | 2023 |
| S143: NATURAL CLONAL EVOLUTION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH BIMODAL CD49D EXPRESSION REVEALS CD49D PLASTICITY E Tissino, N Calonaci, F Pozzo, F Vit, A Gaglio, LTDI Bergamo, T Bittolo, ... HemaSphere 7 (S3), e7042158, 2023 | | 2023 |
| Clonal Evolution of Chronic Lymphocytic Leukemia with Bimodal CD49d Expression Reveals CD49d Plasticity E Tissino, N Calonaci, F Pozzo, G Forestieri, L Terzi Di Bergamo, F Vit, ... Blood 140 (Supplement 1), 9844-9846, 2022 | | 2022 |
| 1697P Drug-induced evolutionary dynamics in BRCA-mutant/non-mutant ovarian cancer models AHIR Garces, S Milite, E Oliveira, J Fernandez-Mateos, B Chen, L Pickard, ... Annals of Oncology 33, S1316, 2022 | | 2022 |
| A study of evolutionary dynamics induced by carboplatin, olaparib and paclitaxel in high-grade serous ovarian cancer cell line models AHIR Garces, S Milite, J Fernandez-Mateos, B Chen, L Pickard, A Stewart, ... Cancer Research 82 (12_Supplement), 3790-3790, 2022 | | 2022 |
| Preprint: Mutation Rate Evolution Drives Immune Escape In Mismatch Repair-Deficient Cancer H Kayhanian, P Barmpoutis, E Lakatos, W Cross, G Caravagna, L Zapata, ... biorxiv. org, 2022 | | 2022 |
